HERON THERAPEUTICS, INC. /DE/ Common Stock Shares Outstanding

Quick Answer

HERON THERAPEUTICS, INC. /DE/ reported Common Stock Shares Outstanding of 188.31 million shares for the year ending 2025.

  • HERON THERAPEUTICS, INC. /DE/ showed an increase of +23.8% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from HERON THERAPEUTICS, INC. /DE/'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), HERON THERAPEUTICS, INC. /DE/'s Common Stock Shares Outstanding has grown by 369.1%.
  • Historical annual values: Fiscal year 2025: 188.31 million shares | Fiscal year 2024: 152.13 million shares | Fiscal year 2023: 150.29 million shares | Fiscal year 2022: 119.15 million shares | Fiscal year 2021: 102.01 million shares | Fiscal year 2020: 91.31 million shares | Fiscal year 2019: 90.30 million shares | Fiscal year 2018: 78.17 million shares | Fiscal year 2017: 64.61 million shares | Fiscal year 2016: 39,355 shares | Fiscal year 2015: 36.11 million shares | Fiscal year 2014: 29.23 million shares | Fiscal year 2013: 23.57 million shares | Fiscal year 2012: 15.11 million shares | Fiscal year 2011: 200.05 million shares | Fiscal year 2010: 40.14 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: